Raji Raveendran

Pt(<scp>iv</scp>) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action

Raji Raveendran, Jeremy Phillip Braude, Ezequiel Wexselblatt et al. · Chemical Science · 2016 · 180 citations · Full text

Medicine, Oncology, Pharmacology +8

New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells

Vojtěch Novohradský, Lenka Zerzánková, Jana Štěpánková et al. · Biochemical Pharmacology · 2015 · 90 citations

Medicine, Oncology, Pharmacology +15

Antitumor platinum(IV) derivatives of oxaliplatin with axial valproato ligands

Vojtěch Novohradský, Lenka Zerzánková, Jana Štěpánková et al. · Journal of Inorganic Biochemistry · 2014 · 77 citations

Medicine, Medicinal Chemistry, Oncology +7

A Lipophilic Pt(IV) Oxaliplatin Derivative Enhances Antitumor Activity

Aiman Abu Ammar, Raji Raveendran, Dan Gibson et al. · Journal of Medicinal Chemistry · 2016 · 77 citations

Medicine, Oncology, Pharmacology +17

Potentiation of mitochondrial dysfunction in tumor cells by conjugates of metabolic modulator dichloroacetate with a Pt(IV) derivative of oxaliplatin

Juraj Zajac, Hana Kostrhunová, Vojtěch Novohradský et al. · Journal of Inorganic Biochemistry · 2015 · 60 citations

Medicine, Medicinal Chemistry, Oncology +16